<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
<channel>
<title>Pharma RSS Feed</title>
<link>http://industry.bnet.com/pharma/feed/rss/</link>
<atom:link href="http://industry.bnet.com/pharma/feed/rss/" rel="self" type="application/rss+xml" />
<description>BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.</description>
<category>Pharma</category>
<language>en-us</language>
<lastBuildDate>Sat, 07 Nov 2009 09:19:14 PST</lastBuildDate>
<ttl>720</ttl>
<item>
	<title><![CDATA[Abbott under kickback probe over Depakote sales -]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/abbott-kickback-probe-depakote-sales/19371/</link>
	<description><![CDATA[
	Abbott Laboratories  this morning confirmed the company's sales and marketing practices of Depakote, the widely used drug to treat  bipolar disorder  and epilepsy, are under federal investigation.  The  U.S. Department of Justice , through the U.S. Attorney for the Western District of  Virginia ,...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/H3evCBwKRAw/">Pharmalot</a> - Abbott Labs Probed Over Depakote Marketing</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/abbott-kickback-probe-depakote-sales/19371/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Fri, 06 Nov 2009 10:34:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[DotW: Sesame Street]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/dotw-sesame-street/19334/</link>
	<description><![CDATA[
	In case you failed to run a Google search this week, you may not have realized that on Tuesday Nov. 10, Sesame Street turns 40. You gotta admit, the show doesn't look a day over five--and that's without Botox.If you've forgotten how to get to Sesame Street, we have a few reminders--and ear...
				<ul>
					<li><a class="source" href="http://www.fiercebiotech.com/story/micromet-takes-back-medimmunes-blinatumomab-rights/2009-11-06?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0">FierceBiotech</a> - Micromet takes back MedImmune's blinatumomab rights</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/dotw-sesame-street/19334/</guid>
	<dc:creator>The In Vivo Blog</dc:creator>
	<pubDate>Fri, 06 Nov 2009 08:20:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Dutch pull Pfizer infant vaccine after deaths]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/dutch-pull-pfizer-infant-vaccine/19315/</link>
	<description><![CDATA[
	Dutch health authorities have yanked a batch of Pfizer's Prevnar following the deaths of three infants. Prevnar, which is known as Prevenar in Europe, is used to protect infants from certain pneumococcal bacteria that can cause meningitis and bacteremia. Pfizer acquired the drug through its...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/xoCjZeognqg/">Pharmalot</a> - Pfizer Vaccine Banned By Dutch Over Infant Deaths</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/dutch-pull-pfizer-infant-vaccine/19315/</guid>
	<dc:creator>FiercePharma</dc:creator>
	<pubDate>Thu, 05 Nov 2009 13:42:02 PST</pubDate>
</item>
<item>
	<title><![CDATA[Roche's Seoul offices raided in Tamiflu probe]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/roches-seoul-offices-raided-tamiflu/19215/</link>
	<description><![CDATA[
	Prosecutors have raided the Seoul office of Roche on suspicions the Swiss drugs group illegally provided Tamiflu to HSBC and Novartis amid fears of a widespread outbreak of swine flu. The South Korean Food and Drug Administration confirmed that prosecutors searched Roche’s office on Wednesday...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/taDOHjCuV3g/">Pharmalot</a> - Roche’s Korean Office Raided Over Tamiflu</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/roches-seoul-offices-raided-tamiflu/19215/</guid>
	<dc:creator>Financial Times</dc:creator>
	<pubDate>Thu, 05 Nov 2009 10:49:41 PST</pubDate>
</item>
<item>
	<title><![CDATA[In DTC TV, longer doesn't have to mean less memorable, says Nielsen]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/dtc-tv-doesnt-memorable-nielsen/19188/</link>
	<description><![CDATA[
	Prescription drug advertisers are running longer broadcast spots to accommodate more expansive fair balance statements, a Nielsen IAG analysis suggests, as 75-second spots proliferate.That's not necessarily bad news for pharma firms, said Nielsen healthcare practice SVP Fariba Zamaniyan, noting...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/MKV_4dafnTc/">Pharmalot</a> - Flomax Was Most-Recalled Drug Ad On TV</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/dtc-tv-doesnt-memorable-nielsen/19188/</guid>
	<dc:creator>Medical Marketing and Media</dc:creator>
	<pubDate>Thu, 05 Nov 2009 06:14:21 PST</pubDate>
</item>
<item>
	<title><![CDATA[Pfizer Must Pay $75M In Damages Over Prempro]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/pfizer-pay-75m-damages-prempro/19090/</link>
	<description><![CDATA[
	The punitive damages will go to an Illinois woman, Connie Barton, who developed cancer after taking Prempro, Bloomberg reports, although the amount was sealed last week by a Pennsyvlania state court judge until another trial begins. A jury also awarded her $3.7 million in compensatory damages...
				<ul>
					<li><a class="source" href="http://pharmagossip.blogspot.com/2009/11/pfizer-prempro-now-thats-punitive.html">PharmaGossip</a> - Pfizer - Prempro: now that's punitive!</li>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/VKXf2NltVIg/">Pharmalot</a> - Pfizer Gets New Trial Over $27M In Prempro Damages</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/pfizer-pay-75m-damages-prempro/19090/</guid>
	<dc:creator>Pharmalot</dc:creator>
	<pubDate>Thu, 05 Nov 2009 04:53:10 PST</pubDate>
</item>
<item>
	<title><![CDATA[United States Department of Justice - the J&J connection]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/united-states-department-justice-connection/18994/</link>
	<description><![CDATA[
	WASHINGTON — The nation’s largest nursing home pharmacy, Omnicare Inc. of Covington, Kentucky, will pay $98 million, and drug manufacturer, IVAX Pharmaceuticals of Weston, Florida, will pay $14 million to resolve allegations that Omnicare engaged in kickback schemes with several parties,...
				<ul>
					<li><a class="source" href="http://www.businessweek.com/bwdaily/dnflash/content/nov2009/db2009114_700374.htm">BusinessWeek</a> - Drugmakers' Payments Draw Heat</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/united-states-department-justice-connection/18994/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Wed, 04 Nov 2009 09:38:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Omnicare settles drug kickbacks probe]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/omnicare-settles-drug-kickbacks-probe/18938/</link>
	<description><![CDATA[
	Another day, another drug-marketing settlement. Omnicare, which provides pharmacy services to nursing homes, agreed to pay $98 million to settle allegations that it accepted and asked for kickbacks, the U.S. Justice Department announced. And Teva Pharmaceutical Industries subsidiary IVAX will pay...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/P2IsprxL_nE/">Pharmalot</a> - Omnicare & Ivax Pay $112M Over Kickback Charges</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/omnicare-settles-drug-kickbacks-probe/18938/</guid>
	<dc:creator>FiercePharma</dc:creator>
	<pubDate>Wed, 04 Nov 2009 08:12:48 PST</pubDate>
</item>
<item>
	<title><![CDATA[J&J to Slash 7,000 to 8,000 Jobs]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/slash-7000-8000-jobs/18696/</link>
	<description><![CDATA[
	NEW YORK (Reuters) - Johnson & Johnson said on Tuesday it plans to cut 6 percent to 7 percent of its workforce in a battle to prop up profits in the face of generic competition to its prescription drugs. The company said the cuts will affect 7,000 to 8,000 jobs, and generate annualized cost...
				<ul>
					<li><a class="source" href="http://feeds.reuters.com/~r/reuters/businessNews/~3/okkXiuJ5-HM/idUSTRE5A229D20091103">Reuters</a> - J&J to cut 7,000 to 8,000 jobs</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/slash-7000-8000-jobs/18696/</guid>
	<dc:creator>Reuters</dc:creator>
	<pubDate>Tue, 03 Nov 2009 07:00:23 PST</pubDate>
</item>
<item>
	<title><![CDATA[BREAKING NEWS: Novartis investing $1B in China R&D ops]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/breaking-news-novartis-investing-1b/18679/</link>
	<description><![CDATA[
	Novartis plans to pump a billion dollars into its R&D operations in China over the next five years, expanding its scientific ranks in the Asian economic powerhouse from 160 to 1,000 as the pharma giant constructs a new research complex designed to rival centers in Europe and the U.S.   The pharma...
				<ul>
					<li><a class="source" href="http://www.fiercebiotechresearch.com/story/novartis-pumping-1b-china-r-d/2009-11-03?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FBR0">FierceMarkets</a> - Novartis pumping $1B into China R&D</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/breaking-news-novartis-investing-1b/18679/</guid>
	<dc:creator>FierceMarkets</dc:creator>
	<pubDate>Tue, 03 Nov 2009 04:36:06 PST</pubDate>
</item>
<item>
	<title><![CDATA[NIH seeds scientific networking projects with $27M]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/nih-seeds-scientific-networking-projects/18700/</link>
	<description><![CDATA[
	Here's something to pass on to the scientists in your life. Over the past few years social networking sites have drawn in millions of people with the promise of instantaneous links to new and old circles of friends. Now the NIH is putting up $27 million to see if the same technology that connects...
				<ul>
					<li><a class="source" href="http://www.fiercebiotech.com/story/drug-researchers-get-their-own-networking-site/2009-11-03?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0">FierceMarkets</a> - Drug researchers get their own networking site</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/nih-seeds-scientific-networking-projects/18700/</guid>
	<dc:creator>FierceMarkets</dc:creator>
	<pubDate>Mon, 02 Nov 2009 12:05:27 PST</pubDate>
</item>
<item>
	<title><![CDATA[BREAKING NEWS: Groundbreaking lupus drug promising in second Phase III]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/breaking-news-groundbreaking-lupus-drug/18493/</link>
	<description><![CDATA[
	Human Genome Sciences and its partner GlaxoSmithKline revealed that the high dose of their experimental lupus therapy demonstrated a statistically superior response compared to placebo in a second late-stage trial, laying the groundwork for an FDA marketing application.   Benlysta has helped...
				<ul>
					<li><a class="source" href="http://feeds.reuters.com/~r/reuters/businessNews/~3/dXUCczL5P_o/idUSTRE5A10XM20091102">Reuters</a> - Human Genome, Glaxo lupus drug works in 2nd trial</li>
					<li><a class="source" href="http://www.in-pharmatechnologist.com/Industry-Drivers/Efficacy-at-Ph-III-lupus-drug-Benlysta-confirms-blockbuster-potential">In-Pharma Technologist</a> - Efficacy at Ph III: lupus drug Benlysta confirms blockbuster potential</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/breaking-news-groundbreaking-lupus-drug/18493/</guid>
	<dc:creator>FierceMarkets</dc:creator>
	<pubDate>Mon, 02 Nov 2009 04:49:07 PST</pubDate>
</item>
<item>
	<title><![CDATA[Study cites concerns over Amgen drugs » Ventura County Star]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/study-cites-concerns-amgen-drugs/18402/</link>
	<description><![CDATA[
	A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick enough to need dialysis.   The study is the largest ever of these blood-boosting...
				<ul>
					<li><a class="source" href="http://www.forbes.com/2009/10/30/amgen-aranesp-anemia-business-healthcare-amgen.html?feed=rss_business">Forbes</a> - Amgen's Anemic Results</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/study-cites-concerns-amgen-drugs/18402/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Sat, 31 Oct 2009 01:48:00 PDT</pubDate>
</item>
<item>
	<title><![CDATA[Shire CEO: Government Probes Are Normal]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/shire-ceo-government-probes-normal/18371/</link>
	<description><![CDATA[
	Another day, another subpoena. And the latest was sent to Shire last month by the US Department of Health and Human Services Office of Inspector General, which is working with the US Attorney in Philadelphia. The focus of their interest is the sales and marketing practices for three ADHD drugs -...
				<ul>
					<li><a class="source" href="http://pharmagossip.blogspot.com/2009/10/shire-subpoenaed-over-adhd-drug.html">PharmaGossip</a> - Shire subpoenaed over ADHD drug marketing</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/shire-ceo-government-probes-normal/18371/</guid>
	<dc:creator>Pharmalot</dc:creator>
	<pubDate>Fri, 30 Oct 2009 14:04:21 PDT</pubDate>
</item>
<item>
	<title><![CDATA[Amgen Sued By 15 States Over Aranesp Kickbacks]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/amgen-sued-15-states-aranesp/18382/</link>
	<description><![CDATA[
	The lawsuit charges Amgen - along with a specialty group purchasing organization known as International Nephrology Network and the ASD Healthcare wholesaler - with offering kickbacks to medical providers to increase sales of its Aranesp anemia drug, Aranesp. The multi-state suit, by the way,...
				<ul>
					<li><a class="source" href="http://pharmagossip.blogspot.com/2009/10/amgen-aranesp-allegedly-rewarding.html">PharmaGossip</a> - Amgen - Aranesp: allegedly rewarding medical providers with kickbacks</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/amgen-sued-15-states-aranesp/18382/</guid>
	<dc:creator>Pharmalot</dc:creator>
	<pubDate>Fri, 30 Oct 2009 14:27:35 PDT</pubDate>
</item>
<item>
	<title><![CDATA[Nemeroff jumps Emory ship for Miami job]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/nemeroff-jumps-emory-ship-miami/18320/</link>
	<description><![CDATA[
	Emory University's controversial psychiatry professor Charles Nemeroff, who was among several high-profile academics targeted by a Senate investigation into financial ties between industry and academia, is taking a new job as psychiatry chair at the University of Miami's Miller School of...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/idjr0WaSrfA/">Pharmalot</a> - Amid Inquiries, Is Nemeroff Looking Beyond Emory?</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/nemeroff-jumps-emory-ship-miami/18320/</guid>
	<dc:creator>Fierce Pharma</dc:creator>
	<pubDate>Fri, 30 Oct 2009 08:33:55 PDT</pubDate>
</item>
<item>
	<title><![CDATA[EMEA links 24th PML case to Tysabri]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/emea-links-24th-pml-tysabri/18326/</link>
	<description><![CDATA[
	European regulators offer yet another update on Tysabri-linked cases of progressive multifocal leukoencephalopathy: The grand total is now 24, up from 23 last week and just 13 some six weeks ago. Of those 24 patients, four died. The numbers are coming thick and fast now because the European Union...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/ruDvp4OyN3s/">Pharmalot</a> - Tysabri Is Now Linked To Four Deaths: EMEA</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/emea-links-24th-pml-tysabri/18326/</guid>
	<dc:creator>Fierce Pharma</dc:creator>
	<pubDate>Fri, 30 Oct 2009 07:30:08 PDT</pubDate>
</item>
<item>
	<title><![CDATA[Deals of the Week: Trick or Treat!]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/deals-trick-treat/18279/</link>
	<description><![CDATA[
	(Top row, L-R: Wyeth, Genentech, Schering-Plough;Middle: Sepracor, CV Therapeutics, NitroMed;Bottom: ImClone, Alpharma, Barr Labs) A memo about costume appropriateness sent home recently by Riverside Drive’s principal made the following points: ¶They should not depict gangs or horror...
				<ul>
					<li><a class="source" href="http://www.fiercebiotech.com/story/breaking-news-medivation-forges-765m-cancer-deal-astellas/2009-10-27?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0">FierceMarkets</a> - BREAKING NEWS: Medivation forges $765M cancer deal with Astellas</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/deals-trick-treat/18279/</guid>
	<dc:creator>The In Vivo Blog</dc:creator>
	<pubDate>Fri, 30 Oct 2009 05:00:00 PDT</pubDate>
</item>
<item>
	<title><![CDATA[AstraZeneca to Pay $520 Million to Settle Four Seroquel Cases - NYT]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/astrazeneca-pay-520-million-settle/18364/</link>
	<description><![CDATA[
	The pharmaceutical company  AstraZeneca  said Thursday that it had reached a $520 million agreement to settle two federal investigations and two whistle-blower lawsuits over the sale and marketing of its blockbuster psychiatric drug Seroquel.    One of the investigations related to “selected...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/ZDUpgdebBhc/">Pharmalot</a> - AstraZeneca Pays $520M To Settle Seroquel Probes</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/astrazeneca-pay-520-million-settle/18364/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Thu, 29 Oct 2009 21:31:00 PDT</pubDate>
</item>
<item>
	<title><![CDATA[Janssen - Risperdal: "probably" busted!]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/janssen-risperdal-busted/18200/</link>
	<description><![CDATA[
	A sales representative for Johnson & Johnson’s Janssen Pharmaceutica unit testified that he encouraged doctors to prescribe the antipsychotic drug Risperdal for unapproved uses.  Matthew D. Thompson, testifying today in a trial over claims by a former co-worker, said that in 2002 he pushed...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/3qox1wxAjx8/">Pharmalot</a> - J&J Sales Rep Told Docs To Use Risperdal Off-Label</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/janssen-risperdal-busted/18200/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Thu, 29 Oct 2009 15:02:00 PDT</pubDate>
</item>
</channel>
</rss>


